Comparison of Effectivity,Security of Repaglinde and Insulin Combined with Metformin of New Diagnostic T2DM

金晖,邱宏玲,蔡若男,徐琳,孙子林

DOI: https://doi.org/10.3969/j.issn.1674-3296.2011.21.005

2011-01-01

Abstract:Objective To compare the effectiveness,security of therapy with repaglinide and insulin combined with metformin of new diagnostic,HbA1c>8.5% T2DM.Methods 75 patients were choosed.40 patients were given repaglinide(group A),and the other 35 patients were given insulin(group B) combined with metformin.After 8 and 16 weeks,we observe the change of HbA1c,fasting blood glucose,postprandial blood glucose,successful control of HbA1c,incidence of hypoglycemia,score of life quality conspicuously.Results The HbA1c of group A reduced(3.41±1.00)% for 8 weeks,(4.26±1.28)% for 16 weeks;and that of group B reduced(3.61±1.63)% for 8 weeks,(4.16±1.55)% for 16 weeks.FPG of group A reduced(4.80±2.05)mmol/L,group B reduced(4.89±2.98)mmol/L for 16weeks.PPG reduced(8.36±4.46)mmol/L in group A,group B reduced(9.21±4.60)mmol/L for 16weeks.The percentage of the patients up to the standard of HbA1c<6.5% and <7.0% of the group A was 25.0%,47.5% and group B 22.9%,51.4% for 8 weeks,group A 60.0%,87.5% and group B 45.7%,74.3% for 16 weeks,respectively.In group A,the rate of well compliance was 37/40.Group B was 15/35.The incidence of hypoglycemia of the group A was lower than group B.The total cost of group A was(1835.10±759.03)yuan,and(2293.30±727.12)yuan in group B.After 16 weeks,the score of life quality of the group A was better than the group B.Conclusion For the patients of new diagnostic T2DM with HbA1c above 8.5%,the effectiveness of repaglinide and insulin together with metformin was equivalency.For the group A,the incidence rate of hypoglycemia was lower,the total cost was lower,the compliance and the quality of life was better.